Sono-Tek (SOTK) Planet MicroCap Showcase: VEGAS 2025 summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Showcase: VEGAS 2025 summary
3 Feb, 2026Company overview and technology
Specializes in ultrasonic atomization technology for thin, precise coatings on products like semiconductor wafers and solar cells.
Founded in 1975, with a strong local team and over 20 years of leadership continuity.
Maintains a significant international presence, with 40–50% of business overseas and customers in over 50 countries.
Holds substantial intellectual property, including patents and proprietary software and electronics.
Operates four global development labs and partners with 39 international distributors.
Market focus and applications
Targets disruptive markets such as microelectronics, medical devices, alternative energy, and food packaging.
Dominates the medical stent coating market and has expanded into diagnostic testing and COVID-related equipment.
Technology is used in products like micro-LEDs, smartwatches, AR/VR devices, and lithium battery protection.
Collaborates with companies to develop barrier coatings for sustainable food containers.
Engages customers in lab-based development to tailor solutions for emerging applications.
Financial performance and growth
Maintains a strong financial position with significant cash reserves and no debt.
Demonstrates a long-term growth trend with consistent gross margins in the high 40s.
Has remained profitable for at least 20 years, with only minor dips due to COVID and supply chain impacts.
Invests in R&D and marketing based on market conditions and internal strategy.
Latest events from Sono-Tek
- 4% revenue growth to $20.5M, $1.27M net income, and strong backlog support near-term growth.SOTK
Q4 20253 Feb 2026 - Record backlog and clean energy demand drive double-digit first half growth and profitability.SOTK
Q2 202519 Jan 2026 - Record backlog and 50% gross margin drive 24% net income growth despite flat sales.SOTK
Q3 202613 Jan 2026 - Record backlog and high-value system sales drive growth in clean energy and tech markets.SOTK
21st Virtual Investor Summit Microcap Event13 Jan 2026 - Record revenue, 150% medical sales growth, and 50% backlog increase offset sector declines.SOTK
Q2 20267 Jan 2026 - Proxy covers director elections, auditor ratification, and executive pay, with focus on governance and oversight.SOTK
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor change, executive pay, and board governance.SOTK
Proxy Filing1 Dec 2025 - Net income rose 47% to $485K as gross margin hit 52% on strong clean energy demand.SOTK
Q1 202610 Jul 2025 - Net income surged on 40% sales growth, led by medical and clean energy demand.SOTK
Q1 202513 Jun 2025